Itamar Shalit
Overview
Explore the profile of Itamar Shalit including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
803
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Neville L, Shalit I, Warn P, Rendell J
J Antimicrob Chemother
. 2022 Mar;
77(6):1706-1709.
PMID: 35229156
Objectives: STM-001, a retargeted glycopeptide, is active against MDR E. coli expressing ESBLs including carbapenemases. Herein, we assessed its capability to combat E. coli complicated urinary tract infections (cUTI) in...
2.
Neville L, Shalit I, Warn P, Scheetz M, Sun J, Chosy M, et al.
Antimicrob Agents Chemother
. 2021 Jan;
65(4).
PMID: 33468474
The ability of vancomycin-arginine (V-r) to extend the spectrum of activity of glycopeptides to Gram-negative bacteria was investigated. Its MIC towards , including β-lactamase expressing Ambler classes A, B, and...
3.
Shkalim-Zemer V, Levi I, Fischer S, Tamary H, Yakobovich J, Avrahami G, et al.
Pediatr Infect Dis J
. 2017 Nov;
37(7):686-690.
PMID: 29140934
Background: Chronic disseminated candidiasis (CDC) is a severe invasive fungal infection principally observed during neutrophil recovery in patients with acute leukemia treated with intensive chemotherapy. Its pathophysiology remains unclear. We...
4.
Tasher D, Rahav G, Levine H, Sofer D, Linder N, Anis E, et al.
Vaccine
. 2015 Dec;
34(3):299-301.
PMID: 26679402
No abstract available.
5.
Lalazar G, Mizrahi M, Turgeman I, Adar T, Ben Yaacov A, Shabat Y, et al.
J Clin Immunol
. 2015 Apr;
35(4):399-407.
PMID: 25876706
Unlabelled: Oral administration of anti-CD3 antibodies induced regulatory T cells (Tregs) alleviating the insulin resistance and liver damage in animal models. Objective: To determine the safety and biological effects of...
6.
Rolnitsky A, Levy I, Sirota L, Shalit I, Klinger G
Eur J Pediatr
. 2012 May;
171(10):1481-7.
PMID: 22628137
Antifungal prophylaxis is increasingly used in very low birth weight (VLBW) infants who are at risk for severe fungal infections. Our objective was to assess the effectiveness of targeted fluconazole...
7.
Hagag S, Kubitschek-Barreira P, Neves G, Amar D, Nierman W, Shalit I, et al.
PLoS One
. 2012 Apr;
7(4):e33604.
PMID: 22514608
Aspergillus fumigatus is the most common opportunistic mold pathogen of humans, infecting immunocompromised patients. The fungus invades the lungs and other organs, causing severe damage. Penetration of the pulmonary epithelium...
8.
Ben-Ami R, Olshtain-Pops K, Krieger M, Oren I, Bishara J, Dan M, et al.
Antimicrob Agents Chemother
. 2012 Feb;
56(5):2518-23.
PMID: 22314534
Recent exposure to azoles is an important risk factor for infection with fluconazole-resistant Candida spp., but little is known about the role of antibacterial drug exposure in the emergence of...
9.
Shouval D, Samra Z, Shalit I, Livni G, Bilavsky E, Bilvasky E, et al.
Isr Med Assoc J
. 2011 Nov;
13(10):605-8.
PMID: 22097229
Background: Staphylococcus aureus infections are a major cause of morbidity and mortality worldwide. Clindamycin is widely used in the treatment of staphylococcal infections; however, it is our impression that in...
10.
Megged O, Stein J, Ben-Meir D, Shulman L, Yaniv I, Shalit I, et al.
J Pediatr Hematol Oncol
. 2011 Feb;
33(3):190-3.
PMID: 21325972
Background: BK-virus-induced hemorrhagic cystitis (BK-HC) is a serious complication in children undergoing hematopoietic stem cell transplantation (HSCT). Data of BK-HC in children undergoing HSCT are still limited. Aim Of The...